ASX:COH

3 Aussie stocks in our sights

Stuart Welch

I recently attended the Brambles investor day in London. Prior to the investor day I scheduled some healthcare related meetings throughout Europe, including attending the International Plasma Protein Congress in Budapest. The healthcare meetings were with various industry participants including the offshore operations of Australian listed healthcare companies, their... Show More

ASX:BXB ASX:COH ASX:CSL australian healthcare

The Rules of Investing: Peter Cooper’s next big idea

Livewire Exclusive

This week’s guest on the podcast is Peter Cooper, founder and Chief Investment Officer of Cooper Investors, one of Australia’s leading boutique investment firms. His success is probably best conveyed by the incredible performance of the CI Brunswick fund, which he manages personally. This fund has outperformed the ASX200 Accumulation... Show More

ASX:COH ASX:CSL ASX:CYB Podcast ASX:SOL ASX:NWL ASX:ELO

See 1 more comment

Who wins if the AUD falls?

Livewire Exclusive

Traditionally, yields on Australian government bonds have been higher than their US counterparts. In fact, the last time US bonds traded at a premium was nearly 20 years ago. That changed recently as a booming US economy and lacklustre Australian economy conspired to drive the differential below zero again. Show More

Key calls on major markets & stocks for the week ahead

James Gerrish

It’s currently very easy to get caught up in the negativity surrounding stocks as a potential Trump-China trade war dominates the press, interestingly something that was not getting any air-time whatsoever 3-months ago nor being touted as a potential ‘threat’ to the market. However let’s stand back and consider what... Show More

ASX:COH ASX:PTM ASX:TLS ASX:WEB

Don't buy value just for value's sake

Michael Wayne

To assist investors in navigating these increasingly uncertain times, we have tried to distill in this wire some of the key themes to emerge out of earnings season. We also nominate one of our top picks in the mid-cap education space with some of the key traits we believe investors... Show More

What Mattered Today; Mkt higher ahead of US inflation print on Wednesday

James Gerrish

The market continued to recover today post last week’s savage selloff with some of the higher risk plays, particularly in the commodity space doing well – the Lithium Miners like Orocobre, Pilbara Minerals and Galaxy topping the leader board today (adding 6%+) while Kidman Resources (KDR) which we hold in... Show More

ASX:CGF ASX:COH ASX:TCL

First Impressions from Reporting: Challenger, GPT Group, Transurban, Boral and Cochlear

Bell Potter

In this daily reporting season update, we provide first impressions on key takeouts from companies reporting today, including Challenger (CGF), GPT Group (GPT), Transurban Group (TCL), Boral (BLD) and Cochlear (COH) with links through to more detailed reports. Show More

ASX:BLD ASX:CGF ASX:COH ASX:GPT ASX:TCL february 2018 reporting season

Make market corrections your ally

Roger Montgomery

Recent experience excepted, corrections are typically more frequent and regular than many would prefer, so investing should not occur without acceptance of this. That said, it’s important to prepare, first by making the right investments, and secondly by adopting the right temperament. Show More

ASX:COH ASX:CSL ASX:RHC ASX:HSO ASX:A2M ASX:AFY ASX:PPH

Join the conversation

The best opportunity in healthcare

Daniel Moore

In this interview, I discuss the best long-term investment opportunities in the sector, which stocks I am cautious on, and what the future holds for the sector as a whole. Show More

Join the conversation

The three characteristics of a quality healthcare company

Daniel Moore

Australia’s Healthcare sector has outperformed all others over the last five years, due to strong demand from investors seeking companies with reliable earnings growth. This has pushed valuations to historically high levels, with some healthcare companies trading at a 50 per cent premium to their global peers, and a 100... Show More

healthcare ASX:COH ASX:CSL

Dogs of the ASX …. Woof Woof!

Hugh Dive

In this week’s piece written from snowy Norway, we are going to look at the “dogs” of the ASX, focusing on large capitalisation Australian companies with falling share prices. Additionally, we are going to sift through the trash of 2017 to try to discern any fallen angels with potential to... Show More

The Case for Owning Quality Stocks Now

Andrew Zenonos

It is no secret that investing in high quality stocks for the long term is a good investment strategy. Russell Investments believes that a premium for high quality stocks exists, in that they will outperform low quality stocks over the long term. We believe that this anomaly exists as investors... Show More

ASX:CTX ASX:COH ASX:CSL ASX:FMG

Aussie tech stocks Versus Alphabet

Sam Granger

There has been some recent commentary from a number of market participants suggesting that the US tech sector is “crowded” and “expensive”. In reality, the valuation of Alphabet compares very favourably to the Australian tech sector and the broader market. Show More

The Global Mid - Small Cap Opportunity

Arik Star

Most Australian investors domestic equity exposure is diversified across large, mid and small cap companies. Mid/small cap companies like Qantas, Treasury Wines, Cochlear, Computershare and NextDC have been some of the best performers on the ASX in recent years benefitting the returns of domestic equity portfolios. However, to date, any... Show More

ASX:COH ASX:CPU ASX:NXT ASX:QAN ASX:TWE ASX:EGI

The cynical power of earnings revisions

UBS Asset Management

The correlation between earnings revisions and share prices and the impact on investor behaviour is well-known. Clearly this suggests either sell-side analysts (rather than actual investors on the buy-side) drive share prices, or most buy-side investors don't form their own views and just follow brokers. Show More

ASX:COH ASX:CPU ASX:CSL ASX:REA ASX:RMD ASX:TWE

Sunset Strip afternoon trading wrap

Mathan Somasundaram

Local market had a slide after flip flopping early in the day. Commodities bounce helped the miners after US Fed, ECB and BOE moved dovish. UK recovery in wages growth and historically low unemployment helps support the economy despite the high inflation and low currency. Show More

First Impressions from Reporting

Bell Potter

In this daily reporting season update, we provide first impressions on key takeouts from companies reporting today, including QBE Insurance (QBE), ASX (ASX), Wesfarmers (WES), Cochlear (COH), Telstra Corporation (TLS), Mirvac (MGR), Tatts Group (TTS), Treasury Wine Estates (TWE) and Adelaide Brighton (ABC) with links through to more detailed reports. Show More

Cochlear Full Year Result: COH expects positive momentum to continue into 2018

CommSec

 COH’s total sales revenue increased by 12% in constant currency (CC) to $1,239.7 million in 2017, while total expenses rose by 10% in CC to $942.7 million. As a result EBIT rose 15% in CC to $315.6 million. The net profit result includes $20.0 million of currency translation impacts... Show More

Morgans reporting season candidates for surprise or disappointment

Andrew Tang

FY17 reporting season kicks off in earnest mid-August and according to the latest IBES consensus earnings estimates, EPS growth for the S&P/ASX200 is forecast at 13% in FY17, slightly down from 13.6% at the end of 1H17. Pleasingly this would still mark the end of the earnings recession after two... Show More

Standout stocks from the research trip

Ned Bell

Only a few companies truly stood out from the 170 we met with on a recent trip. One of them, a smallcap healthcare stock, uses iPhone cameras in single-use, disposable endoscopes, and we forecast earnings to grow 3-fold over the next 4 years. We discuss this and several other standouts... Show More